Nijmegen, Netherlands

Hans Van Eenenneem


Average Co-Inventor Count = 3.0

ph-index = 3

Forward Citations = 225(Granted Patents)


Company Filing History:


Years Active: 2014-2017

Loading Chart...
3 patents (USPTO):Explore Patents

Title: The Innovations of Hans Van Eenenneem

Introduction

Hans Van Eenenneem is a notable inventor based in Nijmegen, Netherlands. He has made significant contributions to the field of immunology, particularly through his work on antibodies targeting the programmed death receptor PD-1. With a total of 3 patents to his name, his innovations are paving the way for advancements in cancer treatment.

Latest Patents

Among his latest patents, Van Eenenneem has developed antibodies that block the binding of human programmed death receptor PD-1 to its ligands, PD-L1 and PD-L2. These antibodies are crucial for enhancing the activity of immune cells by modulating the PD-1 pathway. His work not only includes the antibodies themselves but also methods to increase immune cell activity, which could have profound implications for cancer therapies.

Career Highlights

Throughout his career, Van Eenenneem has worked with prominent organizations such as Merck Sharp & Dohme Corporation and Merck Sharp & Dohme B.V. His experience in these companies has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.

Collaborations

Some of his notable coworkers include Gregory John Carven and Gradus Johannes Dulos. Their collaborative efforts have further enriched the research environment and fostered innovation in the field of immunology.

Conclusion

Hans Van Eenenneem's contributions to the development of PD-1 antibodies represent a significant advancement in immunotherapy. His work continues to inspire future innovations in the fight against cancer.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…